Home › Billing code Q5127
Q5127
Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
Medicaid paid $3.69M on code Q5127 from 2018 through 2024, to 3 providers — the #2,781 code in the file by dollars. 100% of it was billed in California.
28Total paid$3.69M
24GClaims674
Paid per claim line$5K
33Providers billing it3
Box 32 · Location
Where Q5127 is billed
The largest of 1 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.
Ranked
Top providers billing Q5127
| # | Provider | Location | Claims | Paid on Q5127 |
|---|---|---|---|---|
| 1 | Desert Regional Medical Center, INC. | Palm Springs, CA | 295 | $3.03M |
| 2 | Hematology-Oncology Consultants | Hemet, CA | 177 | $581K |
| 3 | California Cancer Associates for Research and Excellence INC | Fresno, CA | 202 | $78K |